Effect of vitamin D on the prognosis of patients with COVID-19

Phase 3

Recruiting

• Conditions: Covid-19.; COVID-19 Disease; U07.02

• Registration Number: IRCT20210327050775N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Being aged 20-70 years
Hospitalization
Positive polymerase chain reaction test (RT-PCR)
No pre-existing already pneumonia, Chronic obstructive pulmonary diseas(COPD) and other respiratory illnesses
No known chronic diseases (diabetes, hypertension, underlying heart disease, infectious, liver, kidney and epilepsy, neuromuscular, immune deficiency diseases and cancer)
Not being hospitalized in the past month
Do not have stressors such as the death of first-degree relatives, etc. in a recent month
Not pregnant
Do not use oral contraceptives, vitamin products, calcium, anticonvulsants, estrogen and diuretics
Do not take injectable vitamin D in the last 6 months
Lack of seasonal sensitivity

Exclusion Criteria

Dissatisfaction or obedience to the treatment to continue participating in the study
Diagnosis of chronic diseases at the time of hospitalization

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnosis and severity disease in patients with Covid 19. Timepoint: Determination of prognosis and severity disease in the beginning of the study (before the intervention) and 7, 14 days after the start of vitamin D intake. Method of measurement: Guidelines issued by the National Health Commission for the diagnosis and treatment of coronavirus.